OPKO Health and Entera Bio, a developer of oral peptides and protein replacement therapies, entered into a license agreement ...
State lawmakers are considering expanding the types of obesity treatments covered by Nevada Medicaid, including approving ...
Investigating GLP-1 RAs reveals their impact on women's health, addressing metabolic disorders, reproductive health, and ...
HealthDay News — Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with better graft and patient survival among kidney transplant recipients with diabetes, according to a study ...
There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...
There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...
The Journal News on MSN1hOpinion
GLP-1 drugs should require eating disorder screening before prescription | OpinionRight now, about 12% of American aged 18 or older (or 1 in 8 adults) are taking GLP-1 — glucagon-like peptide-1 — receptor ...
"The gut microbes we are using now are a mix from healthy donors' fecal samples to ensure a variety of bacteria, but they can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback